Market Cap 5.50B
Revenue (ttm) 2.53B
Net Income (ttm) 265.24M
EPS (ttm) N/A
PE Ratio 20.42
Forward PE 18.37
Profit Margin 10.48%
Debt to Equity Ratio 0.00
Volume 297,600
Avg Vol 205,062
Day's Range N/A - N/A
Shares Out 13.77M
Stochastic %K 15%
Beta 0.46
Analysts Hold
Price Target $461.75

Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractor...

Industry: Medical Care Facilities
Sector: Healthcare
Phone: 513 762 6690
Address:
255 East Fifth Street, Suite 2600, Cincinnati, United States
ZacksResearch
ZacksResearch Feb. 27 at 6:36 PM
$CHE just got crushed — and this isn’t just a “small miss.” ⚠️ Shares slipped 15% after Q4 earnings and revenue both missed estimates, margins contracted, and the 2026 EPS outlook came in below consensus. That’s a triple hit to confidence. When growth stalls and guidance disappoints at the same time, the market reprices fast. See the full breakdown and what this means for the stock 👉 https://www.zacks.com/stock/news/2877001/che-stock-falls-post-q4-earnings-revenue-miss-margins-crash?cid=sm-stocktwits-2-2877001-teaser-35586&ADID=SYND_STOCKTWITS_TWEET_2_2877001_TEASER_35586
0 · Reply
ZacksResearch
ZacksResearch Feb. 27 at 5:36 PM
$CHE drops 15% post-earnings — what’s the downturn about? 📉 Chemed's Q4 adjusted EPS of $6.42 missed the Zacks Consensus Estimate by 8.55%, with revenues also falling short by 2.55%. VITAS saw revenue growth, while Roto-Rooter faced a decline, alongside margin contraction. Full insights here 👉 https://www.zacks.com/stock/news/2877001/che-stock-falls-post-q4-earnings-revenue-miss-margins-crash?cid=sm-stocktwits-2-2877001-body-35587&ADID=SYND_STOCKTWITS_TWEET_2_2877001_BODY_35587
0 · Reply
hunanddone
hunanddone Feb. 26 at 2:25 PM
$CHE I know little to nothing about this stock and company. Apparently none of miss was baked in?? It was at 24 x trailing before this slaughter going sub 20. I would think after a substantial short attack cuz noone will stand up on the bid, it will deadcat for a nice trade. Gonna be watching it
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 25 at 9:45 PM
$CHE Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $5.48 down -9.87% YoY • Reported revenue of $639.34M down -0.10% YoY • Chemed estimates full-year 2026 adjusted diluted EPS between $23.25 and $24.25, with VITAS revenue projected to increase 5.5% to 6.5% and Roto-Rooter revenue growth of 3.0% to 3.5%.
0 · Reply
CapitalInflection
CapitalInflection Feb. 20 at 2:21 PM
$CHE Chemed operates healthcare and hospice services. Cash flows are stable and recurring. Regulatory risk remains manageable.
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 16 at 9:26 PM
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 10 at 9:04 PM
0 · Reply
Estimize
Estimize Jan. 29 at 9:00 PM
Wall St is expecting 5.99 EPS for $CHE Q1 [Reporting 04/29 AMC] http://www.estimize.com/intro/che?chart=historical&metric_name=eps&utm_cont
0 · Reply
BillionerOfKing
BillionerOfKing Jan. 15 at 2:58 PM
$CHE Current Stock Price: $449.37 Contracts to trade: $450 CHE Jan 16 2026 Call Entry: $2.88 Exit: $5.62 ROI: 95% Hold ~22 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 13 at 7:16 PM
$CHE RSI: 59.14, MACD: 3.3780 Vol: 6.87, MA20: 435.67, MA50: 434.42 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Latest News on CHE
Chemed Corporation (CHE) Q4 2025 Earnings Call Transcript

Feb 26, 2026, 3:08 PM EST - 15 days ago

Chemed Corporation (CHE) Q4 2025 Earnings Call Transcript


Chemed Reports Fourth-Quarter 2025 Results

Feb 25, 2026, 4:15 PM EST - 16 days ago

Chemed Reports Fourth-Quarter 2025 Results


Chemed Corporation Declares Quarterly Dividend of 60 Cents

Nov 7, 2025, 11:28 AM EST - 4 months ago

Chemed Corporation Declares Quarterly Dividend of 60 Cents


Chemed Corporation (CHE) Q3 2025 Earnings Call Transcript

Oct 29, 2025, 1:06 PM EDT - 4 months ago

Chemed Corporation (CHE) Q3 2025 Earnings Call Transcript


Chemed Reports Third-Quarter 2025 Results

Oct 28, 2025, 4:15 PM EDT - 4 months ago

Chemed Reports Third-Quarter 2025 Results


Chemed Corporation (CHE) Q2 2025 Earnings Call Transcript

Jul 30, 2025, 3:56 PM EDT - 8 months ago

Chemed Corporation (CHE) Q2 2025 Earnings Call Transcript


Chemed To Report Second-Quarter 2025 Earnings July 29, 2025

Jun 27, 2025, 4:15 PM EDT - 9 months ago

Chemed To Report Second-Quarter 2025 Earnings July 29, 2025


Chemed Corporation (CHE) Q1 2025 Earnings Call Transcript

Apr 24, 2025, 4:14 PM EDT - 11 months ago

Chemed Corporation (CHE) Q1 2025 Earnings Call Transcript


Chemed Reports First-Quarter 2025 Results

Apr 23, 2025, 4:15 PM EDT - 11 months ago

Chemed Reports First-Quarter 2025 Results


Chemed Corporation (CHE) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 2:10 PM EST - 1 year ago

Chemed Corporation (CHE) Q4 2024 Earnings Call Transcript


Chemed Reports Fourth-Quarter 2024 Results

Feb 26, 2025, 4:15 PM EST - 1 year ago

Chemed Reports Fourth-Quarter 2024 Results


Chemed Corporation Declares Quarterly Dividend of 50 Cents

Feb 14, 2025, 1:30 PM EST - 1 year ago

Chemed Corporation Declares Quarterly Dividend of 50 Cents


Chemed Corporation (CHE) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 3:56 PM EDT - 1 year ago

Chemed Corporation (CHE) Q3 2024 Earnings Call Transcript


Chemed Reports Third-Quarter 2024 Results

Oct 29, 2024, 4:15 PM EDT - 1 year ago

Chemed Reports Third-Quarter 2024 Results


Chemed Remains A Buy On Long-Term Economics

Aug 15, 2024, 11:23 PM EDT - 1 year ago

Chemed Remains A Buy On Long-Term Economics


Chemed Corporation (CHE) Q2 2024 Earnings Call Transcript

Jul 25, 2024, 2:27 PM EDT - 1 year ago

Chemed Corporation (CHE) Q2 2024 Earnings Call Transcript


ZacksResearch
ZacksResearch Feb. 27 at 6:36 PM
$CHE just got crushed — and this isn’t just a “small miss.” ⚠️ Shares slipped 15% after Q4 earnings and revenue both missed estimates, margins contracted, and the 2026 EPS outlook came in below consensus. That’s a triple hit to confidence. When growth stalls and guidance disappoints at the same time, the market reprices fast. See the full breakdown and what this means for the stock 👉 https://www.zacks.com/stock/news/2877001/che-stock-falls-post-q4-earnings-revenue-miss-margins-crash?cid=sm-stocktwits-2-2877001-teaser-35586&ADID=SYND_STOCKTWITS_TWEET_2_2877001_TEASER_35586
0 · Reply
ZacksResearch
ZacksResearch Feb. 27 at 5:36 PM
$CHE drops 15% post-earnings — what’s the downturn about? 📉 Chemed's Q4 adjusted EPS of $6.42 missed the Zacks Consensus Estimate by 8.55%, with revenues also falling short by 2.55%. VITAS saw revenue growth, while Roto-Rooter faced a decline, alongside margin contraction. Full insights here 👉 https://www.zacks.com/stock/news/2877001/che-stock-falls-post-q4-earnings-revenue-miss-margins-crash?cid=sm-stocktwits-2-2877001-body-35587&ADID=SYND_STOCKTWITS_TWEET_2_2877001_BODY_35587
0 · Reply
hunanddone
hunanddone Feb. 26 at 2:25 PM
$CHE I know little to nothing about this stock and company. Apparently none of miss was baked in?? It was at 24 x trailing before this slaughter going sub 20. I would think after a substantial short attack cuz noone will stand up on the bid, it will deadcat for a nice trade. Gonna be watching it
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 25 at 9:45 PM
$CHE Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $5.48 down -9.87% YoY • Reported revenue of $639.34M down -0.10% YoY • Chemed estimates full-year 2026 adjusted diluted EPS between $23.25 and $24.25, with VITAS revenue projected to increase 5.5% to 6.5% and Roto-Rooter revenue growth of 3.0% to 3.5%.
0 · Reply
CapitalInflection
CapitalInflection Feb. 20 at 2:21 PM
$CHE Chemed operates healthcare and hospice services. Cash flows are stable and recurring. Regulatory risk remains manageable.
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 16 at 9:26 PM
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 10 at 9:04 PM
0 · Reply
Estimize
Estimize Jan. 29 at 9:00 PM
Wall St is expecting 5.99 EPS for $CHE Q1 [Reporting 04/29 AMC] http://www.estimize.com/intro/che?chart=historical&metric_name=eps&utm_cont
0 · Reply
BillionerOfKing
BillionerOfKing Jan. 15 at 2:58 PM
$CHE Current Stock Price: $449.37 Contracts to trade: $450 CHE Jan 16 2026 Call Entry: $2.88 Exit: $5.62 ROI: 95% Hold ~22 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 13 at 7:16 PM
$CHE RSI: 59.14, MACD: 3.3780 Vol: 6.87, MA20: 435.67, MA50: 434.42 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
ZacksResearch
ZacksResearch Dec. 18 at 12:53 PM
$CHE down 17.4% over the past year — is a turnaround on the horizon? 💡 ✅ VITAS shows strong growth with a 2.5% increase in days-of-care and a 4.1% Medicare reimbursement boost. 🛠️ Roto-Rooter resilient with 1.1% revenue growth and strength in residential plumbing. ⚠️ But watch out for macroeconomic headwinds and competitive pressures. Full details on what's next for $CHE here 👉 https://www.zacks.com/stock/news/2805979/should-investors-hold-chemed-stock-in-their-portfolio-now?cid=sm-stocktwits-2-2805979-body-25344&ADID=SYND_STOCKTWITS_TWEET_2_2805979_BODY_25344
0 · Reply
ZacksResearch
ZacksResearch Dec. 18 at 11:53 AM
Hold or trim $CHE here? The setup isn’t as clean as it looks ⚠️ CHE is seeing growth momentum from VITAS and resilient results at Roto-Rooter, but macro headwinds and competitive pressures are still clouding the near-term outlook. See the full risk/reward breakdown for Chemed here 👉 https://www.zacks.com/stock/news/2805979/should-investors-hold-chemed-stock-in-their-portfolio-now?cid=sm-stocktwits-2-2805979-teaser-25343&ADID=SYND_STOCKTWITS_TWEET_2_2805979_TEASER_25343
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 5 at 9:01 PM
$CHE Current Stock Price: $421.34 Contracts to trade: $420 CHE Dec 19 2025 Call Entry: $8.40 Exit: $14.51 ROI: 73% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Broview
Broview Dec. 5 at 7:02 AM
$CHE spinoff the business lines? Not make sense at all? All values buried
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 13 at 6:05 PM
$CHE Share Price: $449.74 Contract Selected: Jun 18, 2026 $600 Calls Buy Zone: $1.02 – $1.26 Target Zone: $1.64 – $2.00 Potential Upside: 51% ROI Time to Expiration: 216 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
electroboy
electroboy Nov. 12 at 5:18 PM
$CHE ill print money!! Highly inflammable 🤑🤑🤑 I’m giving you an other Runner Like $PFE !! Check my option signal — smart money is about getting in early.
0 · Reply
JarvisFlow
JarvisFlow Nov. 10 at 3:31 PM
RBC Capital has updated their rating for Chemed ( $CHE ) to Outperform with a price target of 572.
0 · Reply
onlythebestcompanies
onlythebestcompanies Oct. 28 at 12:57 PM
$CHE $600 soon.
0 · Reply
Stonksgocraycraycray
Stonksgocraycraycray Oct. 13 at 5:41 PM
$BURU stuck here come to $CHR $CHE $GPUS all ready to rocket up double up those
1 · Reply